Leila Lackey

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Venues

Drug safety

Therapeutic innovation & regulatory science

Food and Drug Administration

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Food and Drug Administration

United States

Operations Research Analyst :: CDER/OSP/OPSA/DSAT

US Environmental Protection Agency

United States

Biologist, Air Team :: ORD/OSP/PSS

US Environmental Protection Agency

United States

Program Analyst, Analysis Staff :: OCFO/OPAA

US Food and Drug Administration

United States

General Health Scientist, Risk Management Staff :: ORA/OPRM

Southern California Coastal Water Research Project

United States

Senior Research Technician :: Biology

University of California Los Angeles

United States

Graduate Student Researcher :: Atmospheric and Oceanic Sciences

Johns Hopkins University Bloomberg School of Public Health

United States

Student Research Assistant :: Environmental Health Sciences

Publications

Arianna Simonetti, Susan Colilla, Brian D Edwards, Jürgen Kübler, Leila Lackey, Lisa Rodriguez, Susan Talbot, Hong Yang, William Wang, Danae Williams, James Matthew Higginson
Key Opinion Leaders' Interviews to Inform the Future of Benefit-Risk Planning in the Medical Total Product Life Cycle of Global Pharmaceutical and Medical Device Organizations. Drug safety 47 (9) (2024)
Arianna Simonetti, Susan Colilla, Brian D Edwards, Jürgen Kübler, Leila Lackey, Lisa Rodriguez, Susan Talbot, Hong Yang, William Wang, Danae Williams, James Matthew Higginson
Key Opinion Leaders' Interviews to Inform the Future of Benefit-Risk Planning in the Medical Total Product Life Cycle of Global Pharmaceutical and Medical Device Organizations. Drug safety 47 (9) (2024)
Arianna Simonetti, Susan Colilla, Brian D Edwards, Jürgen Kübler, Leila Lackey, Lisa Rodriguez, Susan Talbot, Hong Yang, William Wang, Danae Williams, James Matthew Higginson
Key Opinion Leaders' Interviews to Inform the Future of Benefit-Risk Planning in the Medical Total Product Life Cycle of Global Pharmaceutical and Medical Device Organizations. Drug safety (2024)
Arianna Simonetti, Susan Colilla, Brian D Edwards, Jürgen Kübler, Leila Lackey, Lisa Rodriguez, Susan Talbot, Hong Yang, William Wang, Danae Williams, James Matthew Higginson
Key Opinion Leaders' Interviews to Inform the Future of Benefit-Risk Planning in the Medical Total Product Life Cycle of Global Pharmaceutical and Medical Device Organizations. Drug safety 47 (9) (2024)
Leila Lackey, Graham Thompson, Sara Eggers
FDA's Benefit-Risk Framework for Human Drugs and Biologics: Role in Benefit-Risk Assessment and Analysis of Use for Drug Approvals. Therapeutic innovation & regulatory science 55 (1) (2020)

Leila Lackey.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Leila Lackey